Acomplia
weight loss diet pill

ACOMPLIA

Acomplia
Safety and Tolerability

ACOMPLIA 20mg has been evaluated for safety in over 6,300 patients.

In placebo controlled studies the discontinuation rate due to adverse reactions was 15.7% for patients receiving ACOMPLIA.

---

The most common adverse events resulting in discontinuation were nausea, mood alteration with depressive disorders, anxiety and dizziness.

---

ACOMPLIA should not be initiated in patients with hepatic or renal impairment or patients with uncontrolled serious psychiatric illnesses such as major depression.

---